​

Funding Round

Series A - Therini Bio

Series A - Therini Bio

Investment Firm

Overview

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

Announced Date

Apr 27, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Dementia Discovery Fund

Dementia Discovery Fund

Dementia Discovery Fund is a early_stage_venture and seed and venture firm.

MRL Ventures Fund

MRL Ventures Fund

MRL Ventures Fund is a early_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorAlzheimer's Drug Discovery Foundation
Participant InvestorSanofi Ventures
Participant InvestorEli Lilly
Participant InvestorDolby Family Ventures
Participant InvestorSV Health Investors

Round Details and Background

Therini Bio raised $36000000 on 2023-04-27 in Series A

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 08, 2019
Seed Round - Therini Bio
2-9.3M
May 10, 2021
Seed Round - Therini Bio
6-17.0M
Apr 27, 2023
Series A - Therini Bio
8-36.0M
Jan 01, 2023
Grant - Therini Bio
1-3.0M

Recent Activity

There is no recent news or activity for this profile.